|
|
|
Schizophrenia Clinical Trials |
|
Thank you for your interest in clinical trials for Schizophrenia.
Please click "Search" to find Schizophrenia clinical trials and medical research studies or read below for information on Schizophrenia diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 5 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years - NCT00946985-
Conditions: Schizophrenia
Location: Portsmount, VA
- A Dose-Response Study of Modafinil Effects on Cognition in Healthy Adults and in Schizophrenia Patients - NCT00711464-95817
Conditions: Schizophrenia
Location: Sacramento, CA
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence - NCT00737256-80220
Conditions: Schizophrenia - Cocaine Dependence
Location: Denver, CO
- A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) - NCT00677898-21201
Conditions: Schizophrenia - Psychotic Disorders
Location: Baltimore, MD
- A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis - NCT00591318-10032
Conditions: Psychosis - Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-08046
Conditions: Schizophrenia
Location: Willingboro, NJ
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-11701
Conditions: Schizophrenia
Location: Amityville, NY
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-46222
Conditions: Schizophrenia
Location: Indianapolis, IN
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-60194
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-60640
Conditions: Schizophrenia
Location: Chicago, IL
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-73103
Conditions: Schizophrenia
Location: Oklahoma City, OK
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-75115
Conditions: Schizophrenia
Location: Desoto, TX
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-92025
Conditions: Schizophrenia
Location: Escondido, CA
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients. - NCT00845026-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Self-Management Program for Adults With Both Schizophrenia and a Co-Occurring Medical Condition - NCT00525304-21201
Conditions: Schizophrenia
Location: Baltimore, MD
- A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients - NCT00725855-80262
Conditions: Schizophrenia
Location: Denver, CO
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-08046
Conditions: Schizophrenia
Location: Willingboro, NJ
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-10035
Conditions: Schizophrenia
Location: New York, NY
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-60169
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-60640
Conditions: Schizophrenia
Location: Chicago, IL
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-63139
Conditions: Schizophrenia
Location: St Louis, MO
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-75115
Conditions: Schizophrenia
Location: Desoto, TX
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08046
Conditions: Schizophrenia
Location: Willingboro, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08078
Conditions: Schizophrenia
Location: Runnemede, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11366
Conditions: Schizophrenia
Location: Fresh Meadows, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11423
Conditions: Schizophrenia
Location: Holliswood, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-19139
Conditions: Schizophrenia
Location: Philadelphia, PA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20036
Conditions: Schizophrenia
Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30328
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30342
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-60068
Conditions: Schizophrenia
Location: Park Ridge, IL
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67207
Conditions: Schizophrenia
Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67211
Conditions: Schizophrenia
Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77005
Conditions: Schizophrenia
Location: Houston, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77008
Conditions: Schizophrenia
Location: Houston, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90502
Conditions: Schizophrenia
Location: Torrance, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90703
Conditions: Schizophrenia
Location: Cerritos, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90720
Conditions: Schizophrenia
Location: Los Alamitos, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90723
Conditions: Schizophrenia
Location: Paramount, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90805
Conditions: Schizophrenia
Location: Long Beach, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90808
Conditions: Schizophrenia
Location: Long Beach, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-91436
Conditions: Schizophrenia
Location: Glendale, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-92025
Conditions: Schizophrenia
Location: Escondido, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia - NCT00538070-02114
Conditions: Schizophrenia
Location: Boston, MA
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia - NCT00538070-02478
Conditions: Schizophrenia
Location: Belmont, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Boston, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Jamaica Plain, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-03063
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Nashua, NH
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-49503
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Grand Rapids, MI
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-55454
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Minneapolis, MN
- Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia - NCT00149734-80220
Conditions: Schizophrenia
Location: Denver, CO
- Add-on Simvastatin in Schizophrenia Trial - NCT00605995-10032
Conditions: Schizophrenia
Location: New York, NY
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia - NCT00794963-11004
Conditions: Metabolic Syndrome
Location: Glen Oaks, NY
- An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children - NCT01050582-
Conditions: Schizophrenia - Bipolar Disorder - Autistic Disorder - Attention Deficit and Disruptive Behavior Disorders
Location: Glen Oaks, NY
- Antipsychotics and Blood Vessel Function - NCT00585273-52242
Conditions: Bipolar Disorder - Schizophrenia
Location: Iowa City, IA
- Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence - NCT00819689-80220
Conditions: Schizophrenia - Cocaine Dependence
Location: Denver, CO
- Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality - NCT01031433-21228
Conditions: Nicotine Dependence
Location: Catonsville, MD
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08852
Conditions: Schizophrenia
Location: Monmouth Junction, NJ
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08901
Conditions: Schizophrenia
Location: New Brunswick, NJ
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects - NCT00567034-02478
Conditions: Schizophrenia - Psychotic Disorders
Location: Belmont, MA
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21201
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21222
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228A
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228B
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarkers in Schizophrenia - NCT00817336-10962
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Orangeburg, NY
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-06106
Conditions: Schizophrenia - Bipolar
Location: Hartford, CT
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21201
Conditions: Schizophrenia - Bipolar
Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21228
Conditions: Schizophrenia - Bipolar
Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-48201
Conditions: Schizophrenia - Bipolar
Location: Detroit, MI
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-60612
Conditions: Schizophrenia - Bipolar
Location: Chicago, IL
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-75390
Conditions: Schizophrenia - Bipolar
Location: Dallas, TX
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine - NCT00312598-27599
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder - Mood Disorders
Location: Chapel Hill, NC
- Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training - NCT00431223-10035
Conditions: Schizophrenia
Location: New York, NY
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20003
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Washington, DC
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20892
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Bethesda, MD
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-22032
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Fairfax, VA
- Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia - NCT00588731-06511
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Haven, CT
- Cannabis and Schizophrenia: Self-Medication and Agonist Treatment - NCT00946348-03756
Conditions: Schizophrenia - Dual Diagnosis - Schizoaffective Disorder - Psychotic Disorder - Cannabis Use Disorder
Location: Lebanon, NH
- Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation - NCT00801567-02478
Conditions: Bipolar Disorder - Schizophrenia - Healthy Controls
Location: Belmont, MA
- Clinical Trial of Tolcapone for Cognition in Schizophrenia - NCT00044083-20892
Conditions: Schizophrenia
Location: Bethesda, MD
- Cognitive Behavior Therapy and Work Outcome - NCT00810355-46202
Conditions: Schizophrenia
Location: Indianapolis, IN
- Cognitive Skills Training Using Computer for Patients With Severe Mental Illness - NCT01036282-10605
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Cognitive Therapy for Negative Symptoms and Functioning - NCT00350883-19104
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Philadelphia, PA
- Cognitive Training to Enhance VA Work Program Outcomes - NCT00829400-06516
Conditions: Mental Illness - Schizophrenia - Depression - PTSD - Bipolar Disorder
Location: West Haven, CT
- Cognitive-Behavioral Therapy in Veterans With Schizophrenia - NCT00688259-90073
Conditions: Schizophrenia - Schizoaffective Disorder
Location: West Los Angeles, CA
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-07018
Conditions: Schizophrenia
Location: East Orange, NJ
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-10456
Conditions: Schizophrenia
Location: Bronx, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11004
Conditions: Schizophrenia
Location: Glen Oaks, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11030
Conditions: Schizophrenia
Location: Manhasset, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11212
Conditions: Schizophrenia
Location: Brooklyn, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11418
Conditions: Schizophrenia
Location: Jamaica, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-78229
Conditions: Schizophrenia
Location: San Antonio, TX
- Comparison of Video Consent Versus Routine Consent for Participation in Research Studies - NCT00430391-92161
Conditions: Schizophrenia
Location: San Diego, CA
- Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill - NCT00809770-98104
Conditions: Drug Abuse - Schizophrenia - Bipolar Disorder - Major Depressive Disorder
Location: Seattle, WA
- Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia - NCT00136760-02912
Conditions: Schizophrenia and Disorders With Psychotic Features - Tobacco Use Disorder
Location: Providence, RI
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning - NCT00937261-92697
Conditions: Schizophrenia
Location: Irvine, CA
- Coronary Artery Disease (CAD) Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation - NCT00167310-15206
Conditions: Schizophrenia - Schizoaffective Disorder - Major Depression - Bipolar Disorder - Coronary Artery Disease
Location: Pittsburgh, PA
- Ctional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography - NCT00942981-20892
Conditions: Schizoaffective Disorder - Schizophrenia
Location: Bethesda, MD
- Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia - NCT00356317-33146
Conditions: Schizophrenia
Location: Coral Gables, FL
- D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia - NCT00963924-02114
Conditions: Schizophrenia
Location: Boston, MA
- DECIFER: DEpression and Citalopram In First Episode Recovery - NCT01041274-02114
Conditions: Schizophrenia - Schizophreniform Disorder
Location: Boston, MA
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia - NCT00690235-75390
Conditions: Schizophrenia - Schizoaffective Disorder - Diabetes - Weight Gain
Location: Dallas, TX
- Determining Metabolic Effects of Valproate and Antipsychotic Therapy - NCT00167934-63110
Conditions: Schizophrenia
Location: St. Louis, MO
- Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients - NCT00501163-63110
Conditions: Schizophrenia - Cardiovascular Disease
Location: St. Louis, MO
- Dopamine Function and Reward Processing In Schizophrenia - NCT01035996-21201
Conditions: Schizophrenia
Location: Baltimore, MD
- Dopamine Function and Reward Processing In Schizophrenia - NCT01035996-21224
Conditions: Schizophrenia
Location: Baltimore, MD
- D-serine for the Schizophrenia Prodrome - NCT00826202-
Conditions: Schizophrenia Prodrome
Location: Glen Oaks, NY
- D-serine for the Schizophrenia Prodrome - NCT00826202-10962
Conditions: Schizophrenia Prodrome
Location: Orangeburg, NY
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia - NCT00237809-06508
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Haven, CT
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia - NCT00237809-06516
Conditions: Schizophrenia - Schizoaffective Disorder
Location: West Haven, CT
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-04102
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Portland, ME
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-11004
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Glen Oaks, NY
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-48108
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Ann Arbor, MI
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-87131
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Albuquerque, NM
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-95817
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Sacramento, CA
- Early Detection and Intervention for the Prevention of Psychosis, A Multi-Site Study - NCT00531518-97301
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Salem, OR
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder - NCT00395031-10035
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia - NCT01009047-
Conditions: Schizophrenia
Location: Atlanta, GA
- Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia - NCT00338832-92093
Conditions: Schizophrenia
Location: La Jolla, CA
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis - NCT00655239-94591
Conditions: Schizophrenia
Location: San Francisco, CA
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis - NCT00655239-95817
Conditions: Schizophrenia
Location: Davis, CA
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10029
Conditions: Schizophrenia - Psychotic Disorders
Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10035
Conditions: Schizophrenia - Psychotic Disorders
Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-11717
Conditions: Schizophrenia - Psychotic Disorders
Location: W. Brentwood, NY
- Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia - NCT00312962-94121
Conditions: Schizophrenia
Location: San Francisco, CA
- Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia - NCT00435370-77030
Conditions: Smoking Cessation - Schizophrenia
Location: Houston, TX
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-02114
Conditions: Schizophrenia
Location: Boston, MA
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-14623
Conditions: Schizophrenia
Location: Rochester, NY
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-49503
Conditions: Schizophrenia
Location: Grand Rapids, MI
- Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder - NCT00373672-37212
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Nashville, TN
- Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia - NCT00833547-02114
Conditions: Schizophrenia
Location: Boston, MA
- Effects of Motivating People With Schizophrenia to Exercise - NCT00559572-37917
Conditions: Schizophrenia
Location: Knoxville, TN
- Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia - NCT01034085-21201
Conditions: Nicotine Dependence - Schizophrenia
Location: Baltimore, MD
- Effects of Oxytocin Nasal Spray on Social Affiliation - NCT00663039-21228
Conditions: Schizophrenia
Location: Catonsville, MD
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-10605
Conditions: Schizophrenia - Schizoaffective Disorder
Location: White Plains, NY
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-60612
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Chicago, IL
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia - NCT00770237-21228
Conditions: Schizophrenia - Nicotine Dependence
Location: Catonsville, MD
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia - NCT00231335-30033
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Decatur, GA
- Efficacy of Pimozide Augmentation for Clozapine Partial Response - NCT00374244-06508
Conditions: Schizophrenia
Location: New Haven, CT
- Efficacy of Pimozide Augmentation for Clozapine Partial Response - NCT00374244-06516
Conditions: Schizophrenia
Location: West Haven, CT
- Efficacy of Pregnenolone in Patients With Schizophrenia - NCT00615511-10065
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Efficacy of Pregnenolone in Patients With Schizophrenia - NCT00615511-10605
Conditions: Schizophrenia - Schizoaffective Disorder
Location: White Plains, NY
- Efficacy of Social Cognition Training in Schizophrenia - NCT00587561-06510
Conditions: Schizophrenia
Location: New Haven, CT
- Efficacy of Social Cognition Training in Schizophrenia - NCT00587561-06516
Conditions: Schizophrenia
Location: West Haven, CT
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-08046
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Willingboro, NJ
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-10523
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Elmsford, NY
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-11423
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Holliswood, NY
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-34741
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Kissimmee, FL
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-45219
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Cincinnati, OH
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-75062
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Irving, TX
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-78756
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Austin, TX
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-90813
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Long Beach, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92056
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Oceanside, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92108
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: San Diego, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92805
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Anaheim, CA
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms - NCT00922272-92845
Conditions: Schizophrenia and Predominant Negative Symptoms
Location: Garden Grove, CA
- Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings - NCT00001921-20892
Conditions: Healthy - Schizophrenia
Location: Bethesda, MD
- Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness - NCT00500695-08901
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Brunswick, NJ
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder - NCT00501618-10027
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder - NCT00501618-10035
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia - NCT00001198-20892
Conditions: Healthy - Schizophrenia
Location: Bethesda, MD
- Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects - NCT00815854-48109
Conditions: Schizophrenia
Location: Ann Arbor, MI
- Facilitation of NMDA Receptor Function in Patients With Schizophrenia and co-Morbid Alcoholism - NCT00338598-06516
Conditions: Alcoholism - Schizophrenia
Location: West Haven, CT
- Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia - NCT00434980-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder
Location: Boston, MA
- Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia - NCT00434980-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Schizophreniform Disorder
Location: Jamaica Plain, MA
- First Episode Schizophrenia and Cannabis-Related Disorder Study - NCT00573287-03060
Conditions: Cannabis-Related Disorder - Substance-Related Disorders - Schizophrenia - Psychotic Disorders
Location: Nashua, NH
- First Episode Schizophrenia and Cannabis-Related Disorder Study - NCT00573287-03101
Conditions: Cannabis-Related Disorder - Substance-Related Disorders - Schizophrenia - Psychotic Disorders
Location: Manchester, NH
- First Episode Schizophrenia and Cannabis-Related Disorder Study - NCT00573287-03301
Conditions: Cannabis-Related Disorder - Substance-Related Disorders - Schizophrenia - Psychotic Disorders
Location: Concord, NH
- First Episode Schizophrenia and Cannabis-Related Disorder Study - NCT00573287-03756
Conditions: Cannabis-Related Disorder - Substance-Related Disorders - Schizophrenia - Psychotic Disorders
Location: Lebanon, NH
- First Episode Schizophrenia and Cannabis-Related Disorder Study - NCT00573287-03766
Conditions: Cannabis-Related Disorder - Substance-Related Disorders - Schizophrenia - Psychotic Disorders
Location: Lebanon, NH
- FMRI of Cholinergic Mechanisms in Schizophrenia - NCT00692679-80220
Conditions: Schizophrenia
Location: DENVER, CO
- FMRI of Cholinergic Mechanisms in Schizophrenia - NCT00692679-80262
Conditions: Schizophrenia
Location: DENVER, CO
- fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia - NCT01046526-21228
Conditions: Schizophrenia - Psychopathology - Nicotine Dependence
Location: Catonsville, MD
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal - NCT00314613-27509
Conditions: Schizophrenia
Location: Butner, NC
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal - NCT00314613-27710
Conditions: Schizophrenia
Location: Durham, NC
- Functional Rehabilitation for Older Patients With Schizophrenia - NCT00712075-92161
Conditions: Schizophrenia - Aging
Location: San Diego, CA
- Gamma-Amino Butyric Acid (GABA) Deficits and Vulnerability to Cannabinoid-Induced Psychosis (THC-Iomazenil) - NCT00982982-06516
Conditions: Schizophrenia - Mental Disorders - Psychotic Disorders
Location: West Haven, CT
- Genetic Study of Schizophrenia - NCT00001486-20892
Conditions: Psychotic Disorder - Schizoaffective Disorder - Schizophrenia
Location: Bethesda, MD
- Genetic Study of Schizophrenia - NCT00001486-21285
Conditions: Psychotic Disorder - Schizoaffective Disorder - Schizophrenia
Location: Towson, MD
- Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis - NCT00307216-27514
Conditions: Psychotic Disorders - Schizophrenia
Location: Chapel Hill, NC
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder - NCT00297947-10035
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder - NCT00297947-10962
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Orangeburg, NY
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone - NCT00539071-37212
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Nashville, TN
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-02720
Conditions: Schizophrenia
Location: Fall River, MA
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-10032
Conditions: Schizophrenia
Location: New York, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-10962
Conditions: Schizophrenia
Location: Orangeburg, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-11203
Conditions: Schizophrenia
Location: Brooklyn, NY
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-27509
Conditions: Schizophrenia
Location: Butner, NC
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-30912
Conditions: Schizophrenia
Location: Augusta, GA
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-49503
Conditions: Schizophrenia
Location: Grand Rapids, MI
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-75024
Conditions: Schizophrenia
Location: Plano, TX
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms - NCT00403546-87131
Conditions: Schizophrenia
Location: Albuquerque, NM
- Huperzine for Cognitive and Functional Impairment in Schizophrenia - NCT00963846-06519
Conditions: Schizophrenia
Location: New Haven, CT
- Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia - NCT01012830-68105
Conditions: Schizophrenia - Dementia
Location: Omaha, NE
- Illness Management and Recovery for Veterans With Severe Mental Illness - NCT00515671-46202
Conditions: Schizophrenia - Schizo-affective Disorder
Location: Indianapolis, IN
- Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia - NCT00406718-78207
Conditions: Schizophrenia - Schizoaffective Disorder
Location: San Antonio, TX
- Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone - NCT00538642-78229
Conditions: Schizophrenia - Schizoaffective Disorder - Bipolar Disorder
Location: San Antonio, TX
- Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors - NCT00178932-37212
Conditions: Schizophrenia - Schizoaffective Disorder - Bipolar Disorder - Major Depression
Location: Nashville, TN
- Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families - NCT00924976-27599
Conditions: Schizophrenia - Bipolar Disorder - Major Depressive Disorder
Location: Chapel Hill, NC
- Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence - NCT00686153-21228
Conditions: Schizophrenia - Substance Dependence - Smoking
Location: Baltimore, MD
- Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence - NCT01037075-21201
Conditions: Schizophrenia - Drug Abuse/Dependency
Location: Baltimore, MD
- Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence - NCT01037075-21224
Conditions: Schizophrenia - Drug Abuse/Dependency
Location: Baltimore, MD
- Inpatient Evaluation of Adults With Schizophrenia - NCT00001247-20892
Conditions: Psychotic Disorder - Schizophrenia - Schizoaffective - Paranoia - Psychosis
Location: Bethesda, MD
- Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Schizophrenia and Schizoaffective (EOSS) - NCT01027962-27599
Conditions: Schizophrenia
Location: Chapel Hill, NC
- Internal Monitoring of Eye Movement in Schizophrenia - NCT01011101-20892
Conditions: Schizophrenia
Location: Bethesda, MD
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-06851
Conditions: Schizophrenia
Location: Norwalk, CT
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-11418
Conditions: Schizophrenia
Location: Jamaica, NY
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-11423
Conditions: Schizophrenia
Location: Holliswood, NY
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-14215
Conditions: Schizophrenia
Location: Buffalo, NY
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-19131
Conditions: Schizophrenia
Location: Philadelphia, PA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-21045
Conditions: Schizophrenia
Location: Columbia, MD
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-30328
Conditions: Schizophrenia
Location: Atlanta, GA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-32701
Conditions: Schizophrenia
Location: Altamonte Springs, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-32751
Conditions: Schizophrenia
Location: Maitland, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-32763
Conditions: Schizophrenia
Location: Orange City, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-33021
Conditions: Schizophrenia
Location: Hollywood, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-33135
Conditions: Schizophrenia
Location: Miami, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-33613
Conditions: Schizophrenia
Location: Tampa, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-34208
Conditions: Schizophrenia
Location: Bradenton, FL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-38119
Conditions: Schizophrenia
Location: Memphis, TN
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-39232
Conditions: Schizophrenia
Location: Flowood, MS
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-44109
Conditions: Schizophrenia
Location: Cleveland, OH
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-60169
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-63118
Conditions: Schizophrenia
Location: St. Louis, MO
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-69101
Conditions: Schizophrenia
Location: North Platte, NE
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-70115
Conditions: Schizophrenia
Location: New Orleans, LA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-70808
Conditions: Schizophrenia
Location: Baton Rouge, LA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-70809
Conditions: Schizophrenia
Location: Baton Rouge, LA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-73103
Conditions: Schizophrenia
Location: Oklahoma City, OK
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-75115
Conditions: Schizophrenia
Location: DeSoto, TX
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-78754
Conditions: Schizophrenia
Location: Austin, TX
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-80130
Conditions: Schizophrenia
Location: Highlands Ranch, CO
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-85226
Conditions: Schizophrenia
Location: Chandler, AZ
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-87131
Conditions: Schizophrenia
Location: Albuquerque, NM
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-91950
Conditions: Schizophrenia
Location: National City, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-92056
Conditions: Schizophrenia
Location: Oceanside, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-92123
Conditions: Schizophrenia
Location: San Diego, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-92701
Conditions: Schizophrenia
Location: Santa Ana, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-92805
Conditions: Schizophrenia
Location: Anaheim, CA
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia - NCT00705783-98007
Conditions: Schizophrenia
Location: Bellevue, WA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|